Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PI3K/Akt/mTOR signaling pathway in cancer stem cells
Mohsen Karami Fath, Menooa Ebrahimi, Ehsan Nourbakhsh, et al.
Pathology - Research and Practice (2022) Vol. 237, pp. 154010-154010
Closed Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy
Jian Li, Ye Zhang, Pei-Yu Dong, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115087-115087
Open Access | Times Cited: 52
From LncRNA to metastasis: The MALAT1-EMT axis in cancer progression
Riya Thapa, Obaid Afzal, Muhammad Afzal, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 154959-154959
Closed Access | Times Cited: 47
Hallmarks of cancer stemness
Jia-Jian Loh, Stephanie Ma
Cell stem cell (2024) Vol. 31, Iss. 5, pp. 617-639
Closed Access | Times Cited: 37
Predictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 24
Identification of cancer stem cell-related genes through single cells and machine learning for predicting prostate cancer prognosis and immunotherapy
Yaxuan Wang, Li Ma, Jiaxin He, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 21
VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives
Mohammad Malekan, Nikolas K. Haass, Ghasem Rahmatpour Rokni, et al.
Life Sciences (2024) Vol. 345, pp. 122563-122563
Closed Access | Times Cited: 16
Lobaric acid suppresses the stemness potential of colorectal cancer cells through mTOR/AKT
Sultan Pulat, Jaycee Augusto Gumiran Paguiri, Chathurika D. B. Gamage, et al.
BioFactors (2025) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
Targeting Gastric Cancer Stem Cells to Enhance Treatment Response
Xionghui Rao, Chaojun Zhang, Huixing Luo, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2828-2828
Open Access | Times Cited: 49
Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies
Ziyu Ji, Jianlin Shen, Yujian Lan, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 28
From carcinogenesis to therapeutic avenues: lncRNAs and mTOR crosstalk in lung cancer
Md Sadique Hussain, Abdulmalik Saleh Alfawaz Altamimi, Muhammad Afzal, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155015-155015
Closed Access | Times Cited: 25
Harnessing cancer stem cell-derived exosomes to improve cancer therapy
Jianqiang Yang, Yong Teng
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 22
Aberrant N-glycosylation in cancer: MGAT5 and β1,6-GlcNAc branched N-glycans as critical regulators of tumor development and progression
Michelle de-Souza-Ferreira, Érika Elias Ferreira, Julio Cesar Madureira de‐Freitas‐Junior
Cellular Oncology (2023) Vol. 46, Iss. 3, pp. 481-501
Closed Access | Times Cited: 21
Understanding the molecular mechanism responsible for developing therapeutic radiation-induced radioresistance of rectal cancer and improving the clinical outcomes of radiotherapy - A review
Samatha M. Jain, Shruthi Nagainallur Ravichandran, Makalakshmi Murali Kumar, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 11
TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9
Ran Hu, Yu Cao, Yuanyuan Wang, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 7
Macrophage-derived SHP-2 inhibits the metastasis of colorectal cancer via Tie2-PI3K signals
Xueliang Wu, Shaoyu Guan, Yonggang Lu, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 2, pp. 125-139
Open Access | Times Cited: 17
Advancement in precision diagnosis and therapeutic for triple-negative breast cancer: Harnessing diagnostic potential of CRISPR-cas & engineered CAR T-cells mediated therapeutics
Vinayak Nayak, Sushmita Patra, Kshitij RB Singh, et al.
Environmental Research (2023) Vol. 235, pp. 116573-116573
Closed Access | Times Cited: 16
Ginsenoside Rg3 suppresses vasculogenic mimicry by impairing DVL3-maintained stemness via PAAD cell-derived exosomal miR-204 in pancreatic adenocarcinoma
Xufan Cai, Zhaohong Wang, Shengzhang Lin, et al.
Phytomedicine (2024) Vol. 126, pp. 155402-155402
Open Access | Times Cited: 6
Molecular targeted therapies for cutaneous squamous cell carcinoma: recent developments and clinical implications.
H. B. Singh, Hitesh Chopra, Inderbir Singh, et al.
PubMed (2024) Vol. 23, pp. 300-334
Closed Access | Times Cited: 6
Research Progress of Plant-Derived Natural Products against Drug-Resistant Cancer
Wenli Liu, Yuqin Wang, Lijie Xia, et al.
Nutrients (2024) Vol. 16, Iss. 6, pp. 797-797
Open Access | Times Cited: 5
The Antioxidation and Inhibiting Apoptosis Effects of Sini Decoction in Myocardial Ischemia Rats Through Pi3k/Akt and Mapk Signaling Pathway
Y. Zhang, Kailing Yu, Xinxin Chen, et al.
(2025)
Closed Access
FASN inhibition shows the potential for enhancing radiotherapy outcomes by targeting glycolysis, AKT, and ERK pathways in breast cancer
Ching-I Chen, Deng-Yu Kuo, Hui-Yen Chuang
International Journal of Radiation Biology (2025), pp. 1-12
Open Access
CD4 + FOXP3Exon2 + regulatory T cell frequency predicts breast cancer prognosis and survival
Clorinda Fusco, Francesca Di Rella, Antonietta Liotti, et al.
Science Advances (2025) Vol. 11, Iss. 3
Closed Access
Hedgehog and PI3K/Akt/mTOR Signaling Pathways Involvement in Leukemic Malignancies: Crosstalk and Role in Cell Death
Mariaconcetta Sicurella, Marica Chiara, Luca M. Neri
Cells (2025) Vol. 14, Iss. 4, pp. 269-269
Open Access
A Promising Resveratrol Analogue Suppresses CSCs in Non-Small-Cell Lung Cancer via Inhibition of the ErbB2 Signaling Pathway
Tanapon Soonthonsrima, Ismail Dwi Putra, Preeyaphan Phookphan, et al.
Chemical Research in Toxicology (2025)
Closed Access
Cancer Stem Cell Relationship with Pro-Tumoral Inflammatory Microenvironment
Ferenc Sípos, Györgyi Műzes
Biomedicines (2023) Vol. 11, Iss. 1, pp. 189-189
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top